Gianpiero Di leva
Gianpiero Di leva
University of Salford
No verified email
Cited by
Cited by
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia
GA Calin, M Ferracin, A Cimmino, G Di Leva, M Shimizu, SE Wojcik, ...
New England Journal of Medicine 353 (17), 1793-1801, 2005
MicroRNA signatures in human ovarian cancer
MV Iorio, R Visone, G Di Leva, V Donati, F Petrocca, P Casalini, C Taccioli, ...
Cancer research 67 (18), 8699-8707, 2007
MicroRNAs in cancer
G Di Leva, M Garofalo, CM Croce
Annual Review of Pathology: Mechanisms of Disease 9, 287-314, 2014
miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation
M Garofalo, G Di Leva, G Romano, G Nuovo, SS Suh, A Ngankeu, ...
Cancer cell 16 (6), 498-509, 2009
Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development
F Pichiorri, SS Suh, A Rocci, L De Luca, C Taccioli, R Santhanam, ...
Cancer cell 18 (4), 367-381, 2010
EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
M Garofalo, G Romano, G Di Leva, G Nuovo, YJ Jeon, A Ngankeu, J Sun, ...
Nature medicine 18 (1), 74-82, 2012
microRNA-205 regulates HER3 in human breast cancer
MV Iorio, P Casalini, C Piovan, G Di Leva, A Merlo, T Triulzi, S Ménard, ...
Cancer research 69 (6), 2195-2200, 2009
Reprogramming of miRNA networks in cancer and leukemia
S Volinia, M Galasso, S Costinean, L Tagliavini, G Gamberoni, A Drusco, ...
Genome research 20 (5), 589-599, 2010
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer
M Garofalo, C Quintavalle, G Di Leva, C Zanca, G Romano, C Taccioli, ...
Oncogene 27 (27), 3845-3855, 2008
miRNA profiling of cancer
G Di Leva, CM Croce
Current opinion in genetics & development 23 (1), 3-11, 2013
MicroRNA cluster 221-222 and estrogen receptor α interactions in breast cancer
G Di Leva, P Gasparini, C Piovan, A Ngankeu, M Garofalo, C Taccioli, ...
JNCI: Journal of the National Cancer Institute 102 (10), 706-721, 2010
MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways
X Rao, G Di Leva, M Li, F Fang, C Devlin, C Hartman-Frey, ME Burow, ...
Oncogene 30 (9), 1082-1097, 2011
Roles of small RNAs in tumor formation
G Di Leva, CM Croce
Trends in molecular medicine 16 (6), 257-267, 2010
MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non–small-cell lung cancer through BIM down-regulation
G Romano, M Acunzo, M Garofalo, G Di Leva, L Cascione, C Zanca, ...
Proceedings of the National Academy of Sciences 109 (41), 16570-16575, 2012
Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer
C Piovan, D Palmieri, G Di Leva, L Braccioli, P Casalini, G Nuovo, ...
Molecular oncology 6 (4), 458-472, 2012
Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status
G Di Leva, C Piovan, P Gasparini, A Ngankeu, C Taccioli, D Briskin, ...
PLoS Genet 9 (3), e1003311, 2013
MicroRNAs in ovarian carcinomas
N Dahiya, PJ Morin
Endocrine-related cancer 17 (1), F77-F89, 2010
MiR-34a/c-dependent PDGFR-α/β downregulation inhibits tumorigenesis and enhances TRAIL-induced apoptosis in lung cancer
M Garofalo, YJ Jeon, GJ Nuovo, J Middleton, P Secchiero, P Joshi, ...
PloS one 8 (6), e67581, 2013
MicroRNAs: fundamental facts and involvement in human diseases
G Di Leva, GA Calin, CM Croce
Birth Defects Research Part C: Embryo Today: Reviews 78 (2), 180-189, 2006
The role of microRNAs in the tumorigenesis of ovarian cancer
G Di Leva, CM Croce
Frontiers in oncology 3, 153, 2013
The system can't perform the operation now. Try again later.
Articles 1–20